Stefano Poletto

Orbassano, 10043, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.

Journal: International journal of molecular sciences

Published: September 14, 2024

Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.

Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.

Journal: Cells

Published: July 08, 2024

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology.

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology.

Journal: Clinical genitourinary cancer

Published: May 20, 2024

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review.

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review.

Journal: Critical reviews in oncology/hematology

Published: May 17, 2024

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.

Journal: Clinical genitourinary cancer

Published: April 25, 2024

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer.

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer.

Journal: International journal of molecular sciences

Published: October 18, 2023

Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.

Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.

Journal: Cancers

Published: October 10, 2023

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 16, 2023

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 28, 2022

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?

Journal: Research and reports in urology

Published: September 04, 2022

Treatment strategies for patients with diffuse large B-cell lymphoma.

Treatment strategies for patients with diffuse large B-cell lymphoma.

Journal: Cancer treatment reviews

Published: April 22, 2022

Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma.

Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma.

Journal: Journal of clinical medicine

Published: December 27, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026